Influence of aspirin on platelet count and volume in humans

被引:60
作者
Erhart, S
Beer, JH
Reinhart, WH [1 ]
机构
[1] Kantonsspital, CH-7000 Chur, Switzerland
[2] Univ Bern, Dept Internal Med, CH-3012 Bern, Switzerland
关键词
aspirin; glycocalicin; platelets; thrombopoietin;
D O I
10.1159/000040940
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet volume and total platelet mass are parameters of platelet activity and have become a prognostic factor in coronary heart disease. We have studied the influence of aspirin on platelet count, volume and total platelet mass in vitro and in a randomized double-blind, placebo-controlled study in 20 healthy young male volunteers in vivo. Aspirin had no influence in vitro on either platelet count, volume or mass. Repeated blood sampling during a 7-day treatment with 250 mg aspirin daily showed an increased platelet count (7.3% on day 1, 3.0% on day 2, 6.8% on day 4 and 9.3% on day 7; p < 0.01) and total platelet mass (7.2, 5.0, 8.6 and 11.5% on days 1, 2, 4 and 7, respectively, p < 0.01), Aspirin treatment without repeated blood withdrawal had no effect. These data indicate that aspirin may affect the circulating platelet mass under certain conditions.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 27 条
  • [1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [2] BATH PMW, 1993, THROMB HAEMOSTASIS, V70, P687
  • [3] BEER JH, 1994, BLOOD, V83, P691
  • [4] CORASH L, 1990, EXP HEMATOL, V18, P205
  • [5] PLATELET COUNT, MEAN PLATELET VOLUME AND THEIR RELATION TO PROGNOSIS IN CEREBRAL INFARCTION
    DERASMO, E
    ALIBERTI, G
    CELI, FS
    ROMAGNOLI, E
    VECCI, E
    MAZZUOLI, GF
    [J]. JOURNAL OF INTERNAL MEDICINE, 1990, 227 (01) : 11 - 14
  • [6] STIMULATION OF MEGAKARYOCYTOPOIESIS AND THROMBOPOIESIS BY THE C-MPL LIGAND
    DESAUVAGE, FJ
    HASS, PE
    SPENCER, SD
    MALLOY, BE
    GURNEY, AL
    SPENCER, SA
    DARBONNE, WC
    HENZEL, WJ
    WONG, SC
    KUANG, WJ
    OLES, KJ
    HULTGREN, B
    SOLBERG, LA
    GOEDDEL, DV
    EATON, DL
    [J]. NATURE, 1994, 369 (6481) : 533 - 538
  • [7] Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction
    Emmons, RVB
    Reid, DM
    Cohen, RL
    Meng, G
    Young, NS
    Dunbar, CE
    Shulman, NR
    [J]. BLOOD, 1996, 87 (10) : 4068 - 4071
  • [8] KARPATKIN S, 1978, BLOOD, V51, P307
  • [9] THROMBOPOIETIN - THE PRIMARY REGULATOR OF PLATELET PRODUCTION
    KAUSHANSKY, K
    [J]. BLOOD, 1995, 86 (02) : 419 - 431
  • [10] PROMOTION OF MEGAKARYOCYTE PROGENITOR EXPANSION AND DIFFERENTIATION BY THE C-MPL LIGAND THROMBOPOIETIN
    KAUSHANSKY, K
    LOK, S
    HOLLY, RD
    BROUDY, VC
    LIN, N
    BAILEY, MC
    FORSTROM, JW
    BUDDLE, MM
    OORT, PJ
    HAGEN, FS
    ROTH, GJ
    PAPAYANNOPOULOU, T
    FOSTER, DC
    [J]. NATURE, 1994, 369 (6481) : 568 - 571